KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pfizer (PFE) Net Margin (2016 - 2025)

Historic Net Margin for Pfizer (PFE) over the last 17 years, with Q2 2025 value amounting to 0.17%.

  • Pfizer's Net Margin rose 400.0% to 0.17% in Q2 2025 from the same period last year, while for Sep 2025 it was 0.06%, marking a year-over-year increase of 1000.0%. This contributed to the annual value of 0.02% for FY2024, which is 400.0% up from last year.
  • Latest data reveals that Pfizer reported Net Margin of 0.17% as of Q2 2025, which was up 400.0% from 0.05% recorded in Q3 2024.
  • Pfizer's 5-year Net Margin high stood at 0.17% for Q2 2025, and its period low was 1.25% during Q3 2021.
  • Moreover, its 5-year median value for Net Margin was 0.03% (2022), whereas its average is 0.13%.
  • Per our database at Business Quant, Pfizer's Net Margin crashed by -103000bps in 2021 and then skyrocketed by 13700bps in 2022.
  • Over the past 5 years, Pfizer's Net Margin (Quarter) stood at 0.05% in 2021, then crashed by -72bps to 0.09% in 2022, then crashed by -716bps to 0.76% in 2023, then surged by 94bps to 0.05% in 2024, then soared by 478bps to 0.17% in 2025.
  • Its last three reported values are 0.17% in Q2 2025, 0.05% for Q3 2024, and 0.13% during Q2 2024.